Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 44
Filter
1.
Clin Exp Immunol ; 183(2): 175-86, 2016 Feb.
Article in English | MEDLINE | ID: mdl-26404106

ABSTRACT

Active complement mediators play a key role in graft-versus-host diseases, but little attention has been given to the angiogenic balance and complement modulation during allograft acceptance. The complement cascade releases the powerful proinflammatory mediators C3a and C5a anaphylatoxins, C3b, C5b opsonins and terminal membrane attack complex into tissues, which are deleterious if unchecked. Blocking complement mediators has been considered to be a promising approach in the modern drug discovery plan, and a significant number of therapeutic alternatives have been developed to dampen complement activation and protect host cells. Numerous immune cells, especially macrophages, develop both anaphylatoxin and opsonin receptors on their cell surface and their binding affects the macrophage phenotype and their angiogenic properties. This review discusses the mechanism that complement contributes to angiogenic injury, and the development of future therapeutic targets by antagonizing activated complement mediators to preserve microvasculature in rejecting the transplanted organ.


Subject(s)
Complement System Proteins/immunology , Graft Rejection/prevention & control , Microvessels/physiology , Neovascularization, Physiologic , Transplants/blood supply , Transplants/immunology , Complement Activation , Complement Membrane Attack Complex/immunology , Graft vs Host Disease/therapy , Humans , Macrophages/immunology , Molecular Targeted Therapy , Neovascularization, Physiologic/immunology
2.
J Biomed Sci ; 22: 58, 2015 Jul 22.
Article in English | MEDLINE | ID: mdl-26198107

ABSTRACT

The complement system, which contains some of the most potent pro-inflammatory mediators in the tissue including the anaphylatoxins C3a and C5a are the vital parts of innate immunity. Complement activation seems to play a more critical role in tumor development, but little attention has been given to the angiogenic balance of the activated complement mediators and macrophage polarization during tumor progression. The tumor growth mainly supported by the infiltration of M2- tumor-associated macrophages, and high levels of C3a and C5a, whereas M1-macrophages contribute to immune-mediated tumor suppression. Macrophages express a cognate receptors for both C3a and C5a on their cell surface, and specific binding of C3a and C5a affects the functional modulation and angiogenic properties. Activation of complement mediators induce angiogenesis, favors an immunosuppressive microenvironment, and activate cancer-associated signaling pathways to assist chronic inflammation. In this review manuscript, we highlighted the specific roles of complement activation and macrophage polarization during uncontrolled angiogenesis in tumor progression, and therefore blocking of complement mediators would be an alternative therapeutic option for treating cancer.


Subject(s)
Complement C3a/metabolism , Complement C5a/metabolism , Macrophages/metabolism , Neoplasms/metabolism , Neovascularization, Pathologic/metabolism , Animals , Humans , Macrophages/pathology , Neoplasms/pathology , Neovascularization, Pathologic/pathology
3.
Am J Transplant ; 12(3): 718-27, 2012 Mar.
Article in English | MEDLINE | ID: mdl-22300378

ABSTRACT

The passage through the hilar plate during right graft live donor liver transplantation (LDLT) can have dangerous consequences for both donors and recipients. The purpose of our study was to delineate hilar transection and biliary reconstruction strategies in right graft LDLT, with special consideration of central and peripheral hilar anatomical variants. A total of 71 consecutive donors underwent preoperative three-dimensional (3D) CT reconstructions and virtual 3D hepatectomies. A three-modal hilar passage strategy was applied, and its impact on operative strategy analyzed. In 68.4% of cases, type I and II anatomical configurations allowed for an en block hilar transection with simple anastomotic reconstructions. In 23.6% of cases, donors had "difficult" type II and types III/IV hilar bile duct anatomy that required stepwise hilar transections and complex graft biliary reconstructions. Morbidity rates for our early (A) and recent (B) experience periods were 67% and 39%, respectively. (1) Our two-level classification and 3D imaging technique allowed for donor-individualized transhilar passage. (2) A stepwise transhilar passage was favored in types III and IV inside the right-sided hilar corridor. (3) Reconstruction techniques showed no ameliorating effect on early/late biliary morbidity rates.


Subject(s)
Liver Transplantation , Liver/anatomy & histology , Liver/surgery , Living Donors , Adult , End Stage Liver Disease , Female , Hepatectomy , Humans , Image Processing, Computer-Assisted , Liver/diagnostic imaging , Male , Tomography, X-Ray Computed
4.
Eur J Surg Oncol ; 37(9): 798-804, 2011 Sep.
Article in English | MEDLINE | ID: mdl-21767928

ABSTRACT

BACKGROUND: Some surgical centres consider palliative resection (PR) to be superior to double loop bypass (DLB) as treatment for advanced carcinoma of the pancreatic head. We performed a retrospective study with prospectively collected data at a single centre to compare PR and DLB in regard to quality of life (QoL). METHODS: From January 1996 to September 2008, 196 patients were given palliative surgery for advanced pancreatic cancer at the University Hospital of Kiel. Forty-two patients underwent PR and 154 underwent DLB. These groups were compared with regard to survival, post-operative morbidity, and QoL. The EORTC QLQ-C30 was used to assess QoL before surgery, at discharge, three months after surgery, and six months after surgery. RESULTS: The median survival time after PR was 7.5 months (95% CI: 4.95-10.05) and after DLB was 6 months (95% CI: 4.98-7.02; log rank test: p = 0.066). There were no significant differences in mortality and morbidity rates (7.1% and 45.2% for PR; 3.9% and 38.3% for DLB, respectively). Assessment of QoL indicated that patients who underwent PR had more impairment of some functional metrics and increased symptoms compared to those who underwent DLB. CONCLUSION: There was no significant difference in survival or morbidity after PR and DLB, but patients who underwent DLB had better QoL than patients who underwent PR. Therefore, clinicians may want to reconsider the use of PR for patients with advanced pancreatic cancer.


Subject(s)
Adenocarcinoma/surgery , Biliopancreatic Diversion , Palliative Care , Pancreatic Neoplasms/surgery , Pancreaticoduodenectomy , Quality of Life , Adenocarcinoma/mortality , Adult , Aged , Aged, 80 and over , Female , Humans , Male , Middle Aged , Pancreatic Neoplasms/mortality
5.
Eur J Cancer ; 47(8): 1203-10, 2011 May.
Article in English | MEDLINE | ID: mdl-21239167

ABSTRACT

BACKGROUND: Clinicopathologic stage is still the main parameter to evaluate the prognosis of newly diagnosed colorectal cancer (CRC) patients. Although molecular markers have been suggested for follow up of treated CRC patients, their complete clinical application is still under evaluation. MATERIALS AND METHODS: To evaluate the association of immune-related genes with CRC prognosis and survival, a total of 19 single nucleotide polymorphisms (SNPs) were genotyped in 614 German patients within the Kiel cohort (POPGEN). RESULTS: A promoter variant (rs1800872) in the Interleukin-10 (IL-10) gene was associated with an increased lymph node metastasis involvement [odds ratio (OR) = 2.1, 95% confidence interval (CI) = 1.03-4.2, for carriers of the TT genotype]. More importantly, among 582 followed up patients the SNP rs3775291 in the toll-like receptor 3 (TLR-3) gene was associated with CRC specific survival (150 events). Patients carrying the TT genotype had a 93% increased risk of death compared with the CC carriers [hazard ratio (HR) = 1.93, 95% CI 1.14-3.28]. The observed effect of the TLR-3 variant was restricted to stage II patients (HR = 4.14, 95% CI 1.24-13.84) and to patients who did not receive adjuvant therapy (HR = 3.2, 95% CI 1.4-7.7). CONCLUSIONS: Our results may provide additional candidates for risk assessment in stage II CRC patients for treatment decision. Further validation of the presented findings is warranted.


Subject(s)
Colorectal Neoplasms/diagnosis , Colorectal Neoplasms/genetics , Polymorphism, Genetic , Toll-Like Receptor 3/genetics , Aged , Cohort Studies , Female , Germany , Humans , Interleukin-10/genetics , Lymphatic Metastasis , Male , Middle Aged , Odds Ratio , Polymorphism, Single Nucleotide , Prognosis , Promoter Regions, Genetic
6.
Endoscopy ; 42(9): 693-8, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20806153

ABSTRACT

BACKGROUND AND STUDY AIMS: Major leakage from an esophageal anastomosis is a life-threatening surgical complication. Endoscopically guided endoluminal vacuum therapy using polyurethane sponges is a new method for treating such leakage. PATIENTS AND METHODS: Between June 2007 and June 2009, five patients (mean age 68 years) who developed anastomotic leakage after esophageal surgery were prospectively evaluated. After endoscopic diagnosis of a major leakage, polyurethane sponges were endoscopically positioned in the wound cavity of the anastomosis. Continuous suction was applied via drainage tubes fixed to the sponges. Initially sponges were endoscopically changed three times per week. RESULTS: In all five patients treatment was successful. Median time to reduce levels of inflammation markers by 50 % was 10 days for white blood cell (WBC) count and 7 days for C-reactive protein (CRP). The smallest initial wound cavity size was 42 cm (3) and the largest was 157 cm (3). The median duration of drainage was 28 days, with a median of 9 sponge changes and a median time to total cavity closure of 42 days. Two patients needed anastomotic dilation by Savary-Miller bougienage due to stenosis found on further follow-up. One of these patients died of acute severe hemorrhage from an aortoanastomotic fistula after the dilation procedure. CONCLUSIONS: Endoscopically assisted vacuum therapy is a well-tolerated and effective therapeutic option for treatment of major esophageal leaks after surgery. Additional surgery was avoided in all cases. However, the occurrence of a delayed aortoesophageal fistula calls for careful further investigation of this new technique.


Subject(s)
Anastomosis, Surgical/adverse effects , Drainage/methods , Endoscopy, Gastrointestinal/methods , Esophagectomy/adverse effects , Esophagus/surgery , Postoperative Complications/surgery , Aged , Female , Humans , Male , Middle Aged , Pilot Projects , Prospective Studies , Suction/methods , Surgical Sponges , Treatment Outcome , Vacuum
7.
Transplant Proc ; 41(6): 2564-6, 2009.
Article in English | MEDLINE | ID: mdl-19715975

ABSTRACT

Quality of life (QoL) is an outcome criterion of increasing importance after orthotopic liver transplantation (OLT). The background of this development is the dramatic improvement in patient survival rates over the past two decades combined with the question of the quality of this survival. Among 339 OLT performed in Kiel since 1987, 123 recipients (70 males, 53 females) of mean age 56.7 +/- 13.1 years who underwent transplantation between August 1992 and June 2007 were subjected to European Organization for Research and Treatment of Cancer (EORTC) Quality of Life Questionnaire (QLQ) C30 plus a liver transplant specific module to analyze QoL. In addition, we included 40 patients listed for OLT in the univariate and multivariate analyses performed using SPSS13.0. A cohort of healthy individuals served as the control group. QoL (global health) among liver recipients was reduced compared with the control group and improved compared with patients on the waiting list. Comparison of the underlying liver diseases showed a comparable QoL between postalcoholic cirrhosis and cholestatic liver diseases. Retransplantation was accompanied by a significant loss of QoL. Cyclosporine-treated recipients displayed a better QoL compared with those treated with tacrolimus. After establishing a system of continuous, systematic QoL assessment, we combined these results with survival outcomes. Further research must focus on advanced statistical methodology that combines these 2 major outcome parameters (QoL and survival). Furthermore, the influence of medical parameters, such of co-morbidity or immunosuppression, needs to be further established with reference to QoL.


Subject(s)
Liver Transplantation/physiology , Adolescent , Adult , Aged , Appetite , Cognition , Emotions , Female , Health Status , Humans , Liver Diseases/physiopathology , Liver Diseases/psychology , Liver Diseases/surgery , Liver Transplantation/mortality , Liver Transplantation/psychology , Male , Middle Aged , Multivariate Analysis , Postoperative Complications/epidemiology , Postoperative Complications/physiopathology , Reoperation/psychology , Reoperation/statistics & numerical data , Sleep Wake Disorders/epidemiology , Social Behavior , Survival Rate , Survivors , Waiting Lists , Young Adult
8.
Pediatr Transplant ; 13(5): 540-4, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19210267

ABSTRACT

Portal vein thrombosis can occur as a result of primary anomalies, after liver transplantation, and for other reasons. It may result in severe complications secondary to portal hypertension, such as bleeding from esophageal or gastric varices, hypersplenism, or impaired somatic growth. In this retrospective study, we analyzed the outcome of 25 children who underwent a Rex shunt procedure. The following venous grafts were used as the shunt: the autologous internal or external jugular vein (n = 17) or a cryopreserved graft (n = 5); in three patients the umbilical vein was recanalized. The median follow up time was 109 months (range 18 days-146 months). The best results were achieved in patients in whom an autologous jugular vein segment was used as a vascular graft for the Rex shunt (shunt patency of 88%). In patients with a functioning shunt no further lower or upper gastrointestinal bleeding occurred. And in the entire study population hypersplenism syndrome improved after surgery. In our large cohort of pediatric patients, the Rex shunt has shown to be an effective method to eliminate portal hypertension and to revascularize the liver and thereby prevents the possible consequences of long-term portosystemic shunting.


Subject(s)
Hypertension, Portal/therapy , Liver Transplantation/methods , Portal Vein/pathology , Venous Thrombosis/etiology , Adolescent , Child , Child, Preschool , Cohort Studies , Cryopreservation , Female , Humans , Infant , Male , Models, Anatomic , Portasystemic Shunt, Surgical , Retrospective Studies , Treatment Outcome , Umbilical Veins/pathology
9.
Ann Surg Oncol ; 15(7): 1908-17, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18459005

ABSTRACT

BACKGROUND: This study investigates oncological risks and benefits of portal occlusion (PO) in major resection for colorectal liver metastases (CLM). METHODS: Between 1995 and 2004, 107 patients were scheduled for major hepatectomy for CLM. Of these, 53 patients were selected for PO due to insufficient future liver remnant (FLR), and 54 patients had straightforward hepatectomy. Associations of clinicopathologic factors with resectability, and outcome after PO were analyzed. RESULTS: 21 of 53 patients (39.6%) after PO were unresectable. These patients had a significant smaller volume of the FLR than the 32 resected patients after PO (P = .029). In total, 17 patients (80.9%) did not undergo resection due to cancer progression. Among these, 11 patients (52.4%) exhibited either a progression of known metastases located in the occluded lobes, or new metastases in the nonoccluded portion of the liver. In another 4 individuals (19%), the decision against resection resulted from insufficient hypertrophy of the FLR. Following major hepatectomy, the 5-year survival was 43.66%. Although there was a significantly higher rate of extended hepatectomies versus formal hepatectomies (P < .001), more bilobar distributed metastases versus unilobar manifestations (P = .015), and a smaller resection margin (P = .01) in patients who had PO, no adverse effect on mortality, morbidity, recurrence and survival was observed. CONCLUSION: Unresectability after PO is a major problem that warrants multidisciplinary improvements, and randomization to resection with or without PO remains ethically problematic. However, following adequate patient selection, PO may provide a significant survival benefit for patients with prior unresectable CLM.


Subject(s)
Colorectal Neoplasms/surgery , Hepatectomy , Liver Neoplasms/surgery , Portal Vein/surgery , Adult , Aged , Aged, 80 and over , Colorectal Neoplasms/pathology , Embolization, Therapeutic , Female , Humans , Ligation , Liver Neoplasms/secondary , Male , Middle Aged , Patient Selection , Preoperative Care , Risk Factors
10.
Pediatr Transplant ; 9(2): 215-9, 2005 Apr.
Article in English | MEDLINE | ID: mdl-15787796

ABSTRACT

Hypogammaglobulinemia has been reported after solid organ transplantation in adults, however immunoglobulin replacement [intravenous immunoglobulins (IVIG)] is only necessary in a minority of affected patients. We here present three pediatric patients with severe post-transplant hypogammaglobulinemia following liver transplantation (LTx) receiving a cyclosporine-based standard immunosuppression. Patient 1 was transplanted at the age of 10 months for biliary atresia. Eight weeks post-Ltx the serum IgG was 1.7 g/L. Patient 2 was transplanted at the age of 12 yr for acute liver failure. Four weeks post-Ltx the IgG dropped to 2.6 g/L. Patient 3 was transplanted at the age of 4 months for biliary atresia. Ten weeks post-Ltx severe hypogammaglobulinemia (IgG < 1.48 g/L) was diagnosed during a severe infectious complication. Patients 1 and 3 received a steroid bolus therapy for acute graft rejection. All patients had normal IgG concentrations prior to Ltx and lymphocyte subsets were post-operatively in the normal range. There was no extensive loss of protein by ascites. IGIV were replaced in the three patients monthly without further complications. In two of the patients (1 and 3) IVIG therapy was discontinued 8 and 10 months after Ltx when the immunosuppression has been reduced and serum IgG concentrations were found in the normal range without further immunoglobulin replacement. Severe hypogammaglobulinemia is a rare phenomenon following pediatric LTx and seems to be mainly caused by immunosuppressive drugs, however, the exact underlying mechanisms are unclear. A screening for hypogammaglobulinemia is useful after pediatric LTx, especially in patients with an intensified immunosuppression. Moreover, further immunologic research in affected patients is necessary.


Subject(s)
Agammaglobulinemia/etiology , Liver Transplantation/adverse effects , Agammaglobulinemia/drug therapy , Agammaglobulinemia/immunology , Biliary Atresia/surgery , Child , Common Variable Immunodeficiency/etiology , Humans , Immunoglobulin G/blood , Immunoglobulins, Intravenous/therapeutic use , Infant , Liver Failure, Acute/surgery , Lymphocyte Subsets
11.
Pediatr Transplant ; 8(6): 644-8, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15598341

ABSTRACT

The technique of liver splitting offers an effective way of increasing the donor pool and decreasing pediatric waiting list mortality. A donor liver is divided in such a way that the left lateral liver graft can be transplanted into a small child and the right extended liver graft into an adult. This innovative technique did not harm the adult recipient pool. Because of its technical complexity and the initial poor results after split liver transplantation (SLT) this procedure has slowly gained acceptance in the Transplantation Community after its first introduction in 1988 (4). Small children with end stage liver disease suffered the most from the extreme shortage of cadaveric donor organs due to the difficulty of finding size-matched donors. The successful surgical development of SLT and a better donor and recipient selection have led to a reduction of the pediatric pretransplant mortality to nearly zero and to results comparable with those after whole organ transplantation (WLT). By splitting a donor organ into two 'full' hemi-grafts and providing a small adult ( < 60 kg) or a big child ( > 30 kg) with the full left graft and a medium-sized adult (60-80 kg) with the full right graft, a small-for-size situation for adolescents or adults can be avoided and the total number of available grafts can be increased. It is the goal to provide each recipient with its customized graft in the near future. However, splitting for two adults requires high technical skills and profound knowledge of the anatomic variations and should be performed in centers with large transplantation experience.


Subject(s)
Liver Transplantation/methods , Adolescent , Child , Child, Preschool , Female , Graft Survival , Humans , Infant , Liver Transplantation/mortality , Liver Transplantation/statistics & numerical data , Liver Transplantation/trends , Male , Retrospective Studies
12.
Pediatr Transplant ; 8(2): 185-8, 2004 Apr.
Article in English | MEDLINE | ID: mdl-15049800

ABSTRACT

Pharmacokinetic studies in adult and pediatric liver transplant recipients have shown that the C(2) monitoring is superior to the traditional determination of CsA trough levels (C(0)) as an estimate of CsA exposure. However, target reference values for C(2) in very small infants have not been established yet. The objective of our study was to assess the distribution of C(2) levels in the first week following Ltx and to analyze enteral absorption of CsA for this group of patients. We documented CsA C(0) and C(2) levels in 25 infants with a body weight below 10 kg (median 6.8 kg; range 3.0-9.8 kg) in the first 7 days after Ltx. The infants had a median age at transplantation of 7 months (range 0.3-20.0 months). The underlying diagnoses were biliary atresia (n = 17), acute liver failure (n = 4), metabolic disease (n = 4). All children received CsA microemulsion (Neoral, initial 10 mg/kg/day), prednisolone, and two single doses of basiliximab as immunosuppressive drugs. The mean C(0) and C(2) levels were as follows: day 1: C(0) 77.0 +/- 39.6, C(2) 340.5 +/- 140.0 ng/mL; day 2: C(0) 135.5 +/- 53.2, C(2) 467.0 +/- 168.2 ng/mL; day 3: C(0) 146.5 +/- 70.8, C(2) 519.0 +/- 219.1 ng/mL; day 4: C(0) 168.5 +/- 55.1, C(2) 570.0 +/- 163.7 ng/mL; day 5: C(0) 156.5 +/- 38.0, C(2) 612.0 +/- 132.4 ng/mL; day 6: C(0) 177.0 +/- 41.1, C(2) 606.0 +/- 149.2 ng/mL; day 7: C(0) 174.0 +/- 27.2, C(2) 622.0 +/- 98.8 ng/mL (r = 0.82, p < 0.05). This analysis demonstrates that there is a good enteral absorption of CsA in very small children post-Ltx in the early post-operative period. Based on the C(2) levels achieved, we conclude that there is a good correlation between C(0) and C(2) levels even in very small infants.


Subject(s)
Body Weight , Cyclosporine/blood , Immunosuppressive Agents/blood , Liver Transplantation , Administration, Oral , Antibodies, Monoclonal/therapeutic use , Basiliximab , Biliary Atresia/surgery , Cyclosporine/administration & dosage , Drug Monitoring , Follow-Up Studies , Graft Rejection/prevention & control , Graft Survival , Humans , Immunosuppressive Agents/administration & dosage , Infant , Intestinal Absorption , Liver Failure, Acute/surgery , Metabolic Diseases/surgery , Prednisolone/therapeutic use , Prospective Studies , Recombinant Fusion Proteins/therapeutic use
13.
Surg Radiol Anat ; 26(3): 239-44, 2004 Jun.
Article in English | MEDLINE | ID: mdl-14968265

ABSTRACT

In modern surgical and transplantation procedures the recognition of anatomic vascular abnormalities of the hepatic arteries is of greater importance than ever. The purpose of this study was to evaluate and classify these variations with respect to their impact on visceral surgery. A total of 604 selective celiac and superior mesenteric angiographies performed on patients with known or suspected liver cirrhosis or hepatic or pancreatic malignancies and on donors of partial liver grafts were analyzed retrospectively. The vascular anatomy of the liver was classified according to different established systems and with particular attention to rare variations. Hepatic arterial anatomy as considered normal in textbook descriptions was found in 79.1%, an aberrant or accessory left hepatic artery (LHA) arising from the left gastric artery in 3.0% and an aberrant or accessory right hepatic artery (RHA) branching off the superior mesenteric artery in 11.9% of the cases. In 1.4% of the cases there was a combination of anomalies of both the LHA and RHA. Variants of the celiac trunk, double hepatic arteries branching at the celiac trunk or hepatic arteries arising directly from the aorta, occurred in 4.1% of the cases. Further atypical branches of the LHA and RHA were found in 0.5% of the cases. Since the incidence and pattern of different types of hepatic arterial anatomy can require specialized preoperative diagnostic as well as intraoperative strategies, knowledge of these abnormalities and their frequency is of major importance for the surgeon as well as the radiologist.


Subject(s)
Celiac Artery/diagnostic imaging , Hepatic Artery/diagnostic imaging , Mesenteric Artery, Superior/diagnostic imaging , Angiography , Aorta, Abdominal/diagnostic imaging , Celiac Artery/abnormalities , Constriction, Pathologic/diagnostic imaging , Hepatic Artery/abnormalities , Humans , Liver Cirrhosis/diagnostic imaging , Liver Neoplasms/diagnostic imaging , Liver Transplantation/diagnostic imaging , Pancreatic Neoplasms/diagnostic imaging , Peripheral Vascular Diseases/diagnostic imaging , Retrospective Studies , Stomach/blood supply , Tissue Donors
14.
Am J Gastroenterol ; 99(1): 45-51, 2004 Jan.
Article in English | MEDLINE | ID: mdl-14687140

ABSTRACT

BACKGROUND: Despite improvements of diagnostic modalities differentiation between benign and malignant hilar strictures remains a challenge. Hilar neoplasia requires preoperative tissue diagnosis to avoid risk of inappropriate extensive surgery. This is commonly attempted using various techniques at ERCP, which have variable sensitivity and accuracy. We used endosonography-guided fine-needle aspiration (EUS-FNA) for the preoperative diagnosis of hilar cholangiocarcinoma (HC). METHODS: Prospective evaluation of 44 patients (31 male, mean age: 59 yr) with strictures at the liver hilum were diagnosed by CT and/or ERCP. All were suspicious of HC but had inconclusive tissue diagnosis. They underwent EUS-FNA with linear echo endoscope and 22 gauge needles. RESULTS: Adequate material was obtained in 43 of 44 patients. Cytology revealed HC in 26 and other malignancies in 5 patients; 12 had benign results: sclerosing cholangitis (n = 4), primary sclerosing cholangitis (n = 4), inflammation (n = 3), sarcoid-like lesion (n = 1). There were no significant differences in age, lesion size, or echo features among patients with adenocarcinomas, other malignancies, or benign lesions. Thirty-two patients underwent surgery, 2 had autopsy, 10 were followed up clinically. Four of the benign results were false negatives. No complications occurred. Accuracy, sensitivity, and specificity were 91%, 89%, and 100%, respectively. EUS and EUS-FNA changed preplanned surgical approach in 27 of 44 patients. CONCLUSION: These results suggest that EUS-FNA is of value as a new, less-invasive approach for tissue diagnosis of hilar strictures of unknown cause. It was technically feasible without significant risks, when other diagnostic tests were inconclusive and was able to change preplanned management in about half of the patients.


Subject(s)
Bile Duct Neoplasms/diagnosis , Bile Ducts, Intrahepatic , Biopsy, Fine-Needle , Cholangiocarcinoma/diagnosis , Endosonography , Ultrasonography, Interventional , Bile Duct Neoplasms/surgery , Cholangiocarcinoma/surgery , Cholangiopancreatography, Endoscopic Retrograde , Cytodiagnosis , Female , Humans , Male , Middle Aged , Prospective Studies
15.
HPB (Oxford) ; 6(2): 76-82, 2004.
Article in English | MEDLINE | ID: mdl-18333054

ABSTRACT

BACKGROUND: Split liver transplantation offers an attractive way to increase the number of cadaveric grafts. In the past 10 years, it has enabled clinicians to minimise paediatric waiting list mortality. Two major concepts are applied in liver splitting. The more widely accepted approach provides a left lateral and a right extended liver graft to be transplanted into one child and one adult, respectively. To date the results from this technique are comparable to whole organ techniques for both the paediatric and the adult recipient. The second principle of splitting the liver provides two 'full' hemi-grafts-the left side for a small adult or big child and the right for a medium-sized adult patient. Full right/full left splitting is an important means of expanding the adult liver graft pool; however, it is a complex variant of liver transplantation that requires a high level of technical skill and a comprehensive knowledge of possible anatomic variations. Splitting for two adults should be performed in centres with a significant annual volume of liver transplantations, experience with left lateral splitting and an active program of hepatobiliary surgery. This brief review discusses anatomical and technical aspects and summarises the experience of both approaches to split liver transplantation to date.

16.
Chirurg ; 74(10): 951-7, 2003 Oct.
Article in German | MEDLINE | ID: mdl-14605738

ABSTRACT

INTRODUCTION: The increasing shortage of cadaveric organs makes living-related liver transplantation a more and more important option. Safety for the donor has the highest priority, and therefore detailed and thorough evaluation is needed. MATERIALS AND METHODS: All potential donors who had been evaluated at our center from January 2001 to March 2002 ( n=100) were included in a retrospective study to analyse the qualitative, logistical, and economic aspects of the evaluation. RESULTS: Seventy-three percent of the potential donors were found to be unsuitable for living donation during the evaluation process. The main reasons were: uncompatible blood group, availability of cadaveric transplant by Eurotransplant, steatosis of more than 10% of hepatocytes in liver biopsy, insufficient liver volume, and psychosocial reasons. The expenditure for all scheduled investigations was 4,469 euro for a complete evaluation. CONCLUSION: While on the one hand, high standards of the evaluation process must be guaranteed, insufficient reimbursement on the other should not lead centers to reduce either quantity or quality of necessary examinations entered in the evaluation protocol.


Subject(s)
Diagnostic Tests, Routine/economics , Histocompatibility Testing/economics , Liver Transplantation/economics , Living Donors/supply & distribution , Adult , Cadaver , Costs and Cost Analysis/statistics & numerical data , Female , Germany , Health Expenditures/statistics & numerical data , Humans , Male , Middle Aged , Patient Dropouts/statistics & numerical data , Reimbursement Mechanisms/economics , Retrospective Studies
17.
Dtsch Med Wochenschr ; 128(38): 1947-50, 2003 Sep 19.
Article in German | MEDLINE | ID: mdl-14502446

ABSTRACT

HISTORY AND CLINICAL FINDINGS: A 60-year-old woman presented with intermittent fever and pain in the right upper abdomen. The patient had spent the last 30 years in the Middle East and Africa. EXAMINATION: Multiple hepatic lesions with cystic parts were demonstrated sonographically. Ecchinococcosis as well as amoebiasis had been excluded. Laboratory findings showed elevated levels of inflammatory parameters, lactate dehydrogenase (4107 U/l), squamous cell carcinoma antigen and CA -125. The liver enzymes were found to be within the normal range. DIAGNOSIS: A squamous cell carcinoma was detected by liver biopsy. The search for a possible primary site elsewhere in the body yielded negative results, so that the tumor must be regarded as primary in the liver. THERAPY: Because of the diffuse tumour growth surgical resection was impossible. The patient underwent chemotherapy. She died 9 month after the squamous cell carcinoma had been diagnosed. CONCLUSION: This case report and a medline research indicate that hepatic neoplasms sometimes must be suspected in patients with liver cysts.


Subject(s)
Carcinoma, Squamous Cell/etiology , Cysts/complications , Liver Diseases/complications , Liver Neoplasms/etiology , Antineoplastic Agents/therapeutic use , Biopsy, Needle , Carcinoma, Squamous Cell/diagnosis , Carcinoma, Squamous Cell/drug therapy , Cysts/pathology , Diagnosis, Differential , Fatal Outcome , Female , Humans , Liver/diagnostic imaging , Liver/pathology , Liver Diseases/pathology , Liver Neoplasms/diagnosis , Liver Neoplasms/drug therapy , Middle Aged , Tomography, X-Ray Computed , Ultrasonography
20.
Ann Surg ; 234(6): 713-21; discussion 721-2, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11729377

ABSTRACT

OBJECTIVE: To assess and compare the value of split-liver transplantation (SLT) and living-related liver transplantation (LRT). SUMMARY BACKGROUND DATA: The concept of SLT results from the development of reduced-size transplantation. A further development of SLT, the in situ split technique, is derived from LRT, which itself marks the optimized outcome in terms of postoperative graft function and survival. The combination of SLT and LRT has abolished deaths on the waiting list, thus raising the question whether living donor liver transplantation is still necessary. METHODS: Outcomes and postoperative liver function of 43 primary LRT patients were compared with those of 49 primary SLT patients (14 ex situ, 35 in situ) with known graft weight performed between April 1996 and December 2000. Survival rates were analyzed using the Kaplan-Meier method. RESULTS: After a median follow-up of 35 months, actual patient survival rates were 82% in the SLT group and 88% in the LRT group. Actual graft survival rates were 76% and 81%, respectively. The incidence of primary nonfunction was 12% in the SLT group and 2.3% in the LRT group. Liver function parameters (prothrombin time, factor V, bilirubin clearance) and surgical complication rates did not differ significantly. In the SLT group, mean cold ischemic time was longer than in the LRT group. Serum values of alanine aminotransferase during the first postoperative week were significantly higher in the SLT group. In the LRT group, there were more grafts with signs of fatty degeneration than in the SLT group. CONCLUSIONS: The short- and long-term outcomes after LRT and SLT did not differ significantly. To avoid the risk for the donor in LRT, SLT represents the first-line therapy in pediatric liver transplantation in countries where cadaveric organs are available. LRT provides a solution for urgent cases in which a cadaveric graft cannot be found in time or if the choice of the optimal time point for transplantation is vital.


Subject(s)
Liver Transplantation , Living Donors , Adolescent , Child , Child, Preschool , Fatty Liver/etiology , Fatty Liver/pathology , Female , Graft Survival , Humans , Immunosuppressive Agents/therapeutic use , Infant , Liver/blood supply , Liver Transplantation/adverse effects , Liver Transplantation/methods , Liver Transplantation/mortality , Male , Postoperative Complications , Reperfusion Injury/etiology , Reperfusion Injury/pathology , Survival Rate
SELECTION OF CITATIONS
SEARCH DETAIL
...